Washington: The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.
Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are infected with the virus.
But company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 per cent, when accompanied by condoms and counseling.
The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.
Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are infected with the virus.
COMMENTS
Advertisement
German Man, 60, Seventh Person To Be Likely "Cured" Of HIV: Doctors 1,790 People Infected With HIV/AIDS In Tripura In 2023-24 Injection Twice A Year 100% Effective In HIV Treatment: Study 'Entire NEET Paper Solved In 45 Minutes Before Exam?': Top Court To Centre On CCTV, Gym Trainer Picks Up Club, Hits Mumbai Man On Head During Workout "In Order To See...": Trump On Why He Tilted Head Before Assassin Fired Trump Shooter's Father Called Cops About Missing Gun Before Attack: Report Application Process For Chief Engineer, Project Manager Begins Hulk Hogan Tears Off Shirt In Support Of Donald Trump At Republican Event Track Latest News Live on NDTV.com and get news updates from India and around the world.